wERBvRb Ethical and procedural issues Hugh Davies, Chair of Oxford - - PowerPoint PPT Presentation

werbvrb
SMART_READER_LITE
LIVE PREVIEW

wERBvRb Ethical and procedural issues Hugh Davies, Chair of Oxford - - PowerPoint PPT Presentation

The EU Clinical Trial Regulation and children and young people (minors) wERBvRb Ethical and procedural issues Hugh Davies, Chair of Oxford A Research Ethics Committee, UK wERBvRb Just some ideas to start the discussion General issues


slide-1
SLIDE 1

wERBvRb

The EU Clinical Trial Regulation and children and young people (minors)

Ethical and procedural issues

Hugh Davies, Chair of Oxford “A” Research Ethics Committee, UK

slide-2
SLIDE 2

wERBvRb

Just some ideas to start the discussion

slide-3
SLIDE 3

wERBvRb

General issues (with some bearing on minors)

  • Balancing research promotion and protection of participants
  • Transparency
  • Lay summary
  • Waiving consent in emergencies

Issues specific to children and young people

  • “Children or adult” debate – “Children are not little adults”
  • Minor and parental involvement
  • Consent / Assent / Dissent
  • Payments
  • Nontherapeutic research

Procedures with consequences for children and young people

  • (The portal)
  • (Part 1 and Part 2)
  • Lay representation, patient voices, and expertise

Summary, conclusions and what next?

slide-4
SLIDE 4

wERBvRb

Balancing research promotion and protection

  • f participants

There is a wish to promote research by making it easer to do

  • Low intervention trials
  • Facilitating non commercial sponsorship
  • Recognising the needs of orphan diseases
  • Promoting further research
slide-5
SLIDE 5

wERBvRb

Transparency (and all that that entails)

slide-6
SLIDE 6

wERBvRb

Lay summaries of research Writing for parents and children?

slide-7
SLIDE 7

wERBvRb

Waiving consent in emergencies (Harmonisation)

slide-8
SLIDE 8

wERBvRb

What it gives with one hand, with the other tied behind its back (or bound to other legislation)…..

  • 1. “Incapacitated subjects, minors, pregnant

women and breastfeeding women require specific protection measures.”

  • 2. Directive 95/46/EC Data Protection Directive

(soon to be a Regulation)

slide-9
SLIDE 9

wERBvRb

Issues specific to children and young people

  • Children vs adult debate
  • Minor and parental involvement
  • Consent / Assent / Dissent
  • Payments
  • Nontherapeutic trials
slide-10
SLIDE 10

wERBvRb

Children vs adult debate Is it true that “Children are not little adults”? Or is this the plaintive cry of the union of child health care professionals (of which I am one) protecting their turf? A more sophisticated, realistic debate is needed.

slide-11
SLIDE 11

wERBvRb

Involvement of children and young people in research A VERY central part of the Nuffield Council of Bioethics report http://nuffieldbioethics.org/project/children- research

slide-12
SLIDE 12

wERBvRb

Consent – not much change? Assent - a legal issue Dissent - not much help or guidance

slide-13
SLIDE 13

wERBvRb

Payments to children Is it ethical to pay adults but not children? Do we believe parents will put their children into studies for profit (and professionals will collude)?

slide-14
SLIDE 14

wERBvRb

Non therapeutic clinical trials involving minors

A very difficult issue Given the conditions placed on this research, the position remains uncertain. Are we any further on than one piece of guidance in 2000 which concluded “It’s not necessarily unethical”?

slide-15
SLIDE 15

wERBvRb

Procedures specific to children and young people

  • Lay representation, patient voices, and expertise
slide-16
SLIDE 16

wERBvRb

Lay representation, patient voices, and expertise Rising expectations but details derogated to member states http://nuffieldbioethics.org/project/children- research

slide-17
SLIDE 17

wERBvRb

Summary and some conclusions

slide-18
SLIDE 18

wERBvRb

Regulation and research involving minors Where we are now. Let us not expect too much of Regulation. It’s written, published and to be implemented, so where can we exert influence?

slide-19
SLIDE 19

wERBvRb

Quo vadis?

  • Grasp opportunities when putting the Clinical

Trial Regulation into practice (avoiding the street gossip or over interpretation - interpreting it in accordance with its philosophy – courage!).

  • Debate the balance for the 21st century (not

19th ) freeing ourselves from history.

  • Proactive contribute to revision of E11 –

“Ethical considerations for clinical trials on medicinal products conducted with the paediatric population”.

  • Watch for the Data Protection Regulation
  • Plan for the next set of Regulations!
slide-20
SLIDE 20

wERBvRb

Promoting research and protecting ALL children - a never ending balancing act for every generation …. and one day they will be grown ups and see the issue from the other side!